Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001387131-17-005721
Filing Date
2017-12-06
Accepted
2017-12-06 15:41:59
Documents
1
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 AMENDED OWNERSHIP DOCUMENT hirschman-form4a_041317.html 4/A  
1 AMENDED OWNERSHIP DOCUMENT hirschman-form4a_041317.xml 4/A 7333
  Complete submission text file 0001387131-17-005721.txt   8897
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Reporting) CIK: 0001131362 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35963 | Film No.: 171242231

Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations